However, this does not mean that the vaccine is being sold free of cost to the government.
In an interview to news agency, AP, Adar Poonawalla the CEO of the Serum Institute of India, the vaccine manufacturer behind Covishield – a two dose vaccine – has stated that they will provide the first 100 million doses of the vaccine to the Government of India at Rs 200 rupees per dose.
While Bharat Biotech hasn’t officially announced a price, company founder Dr Krishna Ella has said, “The cost depends on the size of volume. The price will be controlled by market. Initially, the price may be high but it will come down as more players enter the market.”
Ministers of several states have announced that they will administer the vaccine free of cost to their residents, such as Delhi, Telangana, Kerala and Tamil Nadu.
According to a BBC report, the costliest vaccine in the US, Moderna is priced at Rs 2,414.15, Pfizer-BioNTech is priced at Rs 1,463.12 and the Oxford-AstraZeneca at Rs…
